Literature DB >> 20715293

Surgeons and selection of adjuvant therapy for node-negative colonic cancer.

P G Horgan1, D C McMillan.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20715293     DOI： 10.1002/bjs.7254

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  7 in total

1.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

2.  Preoperative inflammatory response as prognostic factor of patients with colon cancer.

Authors:  Daiki Matsubara; Tomohiro Arita; Masayoshi Nakanishi; Yoshiaki Kuriu; Yasutoshi Murayama; Michihiro Kudou; Katsutoshi Shoda; Toshiyuki Kosuga; Hirotaka Konishi; Ryo Morimura; Atsushi Shiozaki; Hisashi Ikoma; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Langenbecks Arch Surg       Date:  2019-08-29       Impact factor: 3.445

3.  Emergency presentation of node-negative colorectal cancer treated with curative surgery is associated with poorer short and longer-term survival.

Authors:  Raymond Oliphant; David Mansouri; Gary A Nicholson; Donald C McMillan; Paul G Horgan; David S Morrison
Journal:  Int J Colorectal Dis       Date:  2014-03-22       Impact factor: 2.571

Review 4.  Optimizing the detection of venous invasion in colorectal cancer: the ontario, Canada, experience and beyond.

Authors:  Heather Dawson; Richard Kirsch; David K Driman; David E Messenger; Naziheh Assarzadegan; Robert H Riddell
Journal:  Front Oncol       Date:  2015-01-05       Impact factor: 6.244

5.  Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.

Authors:  James H Park; Arfon G Powell; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; Joanne Edwards
Journal:  Br J Cancer       Date:  2016-02-09       Impact factor: 7.640

6.  Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer.

Authors:  Qing-Bin Wu; Meng Wang; Tao Hu; Wan-Bin He; Zi-Qiang Wang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer.

Authors:  Raymond Oliphant; Paul G Horgan; David S Morrison; Donald C McMillan
Journal:  Cancer Med       Date:  2014-12-08       Impact factor: 4.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.